What does it take to turn groundbreaking science into life-saving treatments?

In this episode of Defining the Future, Claire Rutherford is joined by Prof Carrie Ambler. Carrie is a Professor at Durham University and the Chief Scientific Officer at LightOx Ltd, a pioneering company dedicated to developing novel chemicals for targeted phototherapies, particularly for oral cancer and wound care.

Since founding LightOx in 2016, Carrie has been instrumental in advancing the company's innovative approach to cancer treatment. Her diverse background, which includes significant experience in the health and life sciences industry, has equipped her with the expertise needed to lead LightOx's scientific and commercial endeavours.

Carrie is deeply involved in all aspects of the business, from investment and clinical trials to regulatory and laboratory work. Her leadership and vision have been crucial in steering LightOx towards clinical trials and expanding its therapeutic pipeline.

Carrie shares her journey from academia to the startup world, the challenges of drug development, and the importance of purpose in their work. The conversation also touches on future aspirations and the balance between personal life and professional responsibilities.

Find out more about LightOx:

Website: https://lightox.co.uk/

Connect with me:

LinkedIn: https://www.linkedin.com/in/claire-rutherford/

Definition IP: https://definitionip.com/